Today's Pre-Open Stock Movers

Kodak (NYSE: KODK) +50%; In a 13G filing on EASTMAN KODAK COMPANY (NYSE: KODK), hedge fund D. E. Shaw & Co., INC. disclosed a 5.2%, or 3,943,770 share, stake in the company.

Zoom (NASDAQ: ZM) +38%; reported Q2 EPS of $0.92, $0.47 better than the analyst estimate of $0.45. Revenue for the quarter came in at $663.5 million versus the consensus estimate of $500.45 million. GUIDANCE: Zoom sees FY2021 EPS of $2.40-$2.47, versus the consensus of $1.30. Zoom sees FY2021 revenue of $2.37-2.39 billion, versus the consensus of $1.81 billion.

Gogo (NASDAQ: GOGO) +28.4%; shares climbed post-market Monday after a bankruptcy judge approved Intelsat's bid for the company's commercial unit in a hearing, according to a report from Bloomberg.

Priority Technology Holdings (NASDAQ: PRTH) +24%; MRI Software (“MRI”), a global leader in real estate software solutions, and Priority Technology Holdings, Inc. (NASDAQ: PRTH) (“Priority”), a leading provider of merchant acquiring, integrated payment software and commercial payment solutions, have entered into a strategic agreement in real estate payments.

Athenex (NASDAQ: ATNX) +22%; today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s New Drug Application (NDA) for oral paclitaxel and encequidar (Oral Paclitaxel) for the treatment of metastatic breast cancer and has granted the application Priority Review. The FDA grants Priority Review to applications for potential drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications

T2 Biosystems (NASDAQ: TTOO) +15%; today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its COVID-19 molecular diagnostic test, the T2SARS-CoV-2™ Panel.

Genworth Financial (NYSE: GNW) +12%; Today, Genworth confirmed that its Board of Directors and management team determined that Oceanwide has provided satisfactory information regarding its funding plan for the purchase price consideration of approximately $2.7 billion, and Genworth therefore does not intend to exercise its right to terminate the merger agreement as of August 31, 2020.

CrowdStrike Holdings Inc. (NASDAQ: CRWD) +8%; Jefferies analyst John DiFucci reiterated a $115.00 price target on CrowdStrike Holdings (NASDAQ: CRWD) on the belief that the company will beat F2Q estimates for ARR growth of 73% and rev growth of 74% but also the Hold rating on the belief that the beat may not be good enough to support the current valuation.

Medicinova (NASDAQ: MNOV) +8%; MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a viral vector platform technology developed by Mie University and BioComo.

Slack (NYSE: WORK) +6.6%; DocuSign Inc. (NASDAQ: DOCU) +13.5%; shares higher in sympathy with Zoom.

Zosano Pharma (NASDAQ: ZSAN) -14.7%; today announced that it has commenced an underwritten public offering of shares of its common stock.

Brinker International (NYSE: EAT) -2%; Raymond James analyst Brian Vaccaro downgraded Brinker Int'l (NYSE: EAT) from Outperform to Market Perform with a price target of $40.00.